University Hospitals Birmingham NHS Foundation Trust

Loading results...
View full results list

Medicines A–Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

D

Status	Drug name	NICE TAs	Comments
	Dabigatran capsules	TA249 - Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation TA327 - Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism	Following diagnosis of AF – use in line NICE and toolkit, initiation/recommendation by haematologist, transfer to GP with RICaD. For the treatment and secondary prevention of DVT and/or PE - use in line with NICE. Initiation/recommendation by haematologist, transfer to GP with RICaD Adults only
	Dabigatran capsules #2.8		Use following hip and knee surgery – full course of treatment supplied on discharge
	Dabrafenib	TA321 - Dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma TA544 - Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma
	Dabrafenib with trametinib	TA898 - Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer
	Dacarbazine injection		For hospital use only
	Daclizumab concentrate for infusion	TA441 - Daclizumab for treating relapsing–remitting multiple sclerosis	For Hospital Use Only. Please see drug safety alert. Safety alert
	Dacomitinib	TA595 - Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer
	Dactinomycin injection		For hospital use only
	Daktacort cream	TA85 - Frequency of application of topical corticosteroids for atopic eczema	Mild potency
	Danaparoid injection		Hospital use only

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next page
Last page

Building healthier lives